BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37878899)

  • 1. Leptin Increase During Dexamethasone and Its Association With Hunger and Fat in Pediatric Acute Lymphoblastic Leukemia.
    van Hulst AM; Verwaaijen EJ; van den Berg SAA; van Litsenburg RRL; Grootenhuis MA; Fiocco M; Neggers SJCMM; van den Heuvel-Eibrink MM; van den Akker ELT
    J Clin Endocrinol Metab; 2024 Feb; 109(3):631-640. PubMed ID: 37878899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical frailty deteriorates after a 5-day dexamethasone course in children with acute lymphoblastic leukemia, results of a national prospective study.
    Verwaaijen EJ; van Hulst AM; Hartman A; Pieters R; Fiocco M; Pluijm SMF; van Litsenburg RRL; Grootenhuis MA; van den Akker ELT; van den Heuvel-Eibrink MM
    Cancer Med; 2023 Dec; 12(24):22304-22315. PubMed ID: 38069550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia.
    Wallace AM; Tucker P; Williams DM; Hughes IA; Ahmed SF
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):770-6. PubMed ID: 12780755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of maintenance therapy on sleep-wake rhythms and cancer-related fatigue in pediatric acute lymphoblastic leukemia.
    Steur LMH; Kaspers GJL; van Someren EJW; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Grootenhuis MA; van Litsenburg RRL
    Support Care Cancer; 2020 Dec; 28(12):5983-5993. PubMed ID: 32285260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
    van Hulst AM; van den Akker ELT; Verwaaijen EJ; Fiocco M; Rensen N; van Litsenburg RRL; Pluijm SMF; Zwaan CM; van Santen HM; Pieters R; Evers AWM; Grootenhuis MA; van den Heuvel-Eibrink MM
    Eur J Cancer; 2023 Jul; 187():124-133. PubMed ID: 37149961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eating behavior during dexamethasone treatment in children with acute lymphoblastic leukemia.
    Warris LT; van den Akker ELT; Bierings MB; van den Bos C; Aarsen FK; Zwaan MC; Tissing WJE; Veening MA; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia.
    Hinds PS; Hockenberry MJ; Gattuso JS; Srivastava DK; Tong X; Jones H; West N; McCarthy KS; Sadeh A; Ash M; Fernandez C; Pui CH
    Cancer; 2007 Nov; 110(10):2321-30. PubMed ID: 17926333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?
    van Hulst AM; Grootenhuis MA; Verwaaijen EJ; van Litsenburg RRL; Li L; van Zelst BD; Broer L; Pluijm SMF; Pieters R; Fiocco M; van den Akker ELT; van den Heuvel-Eibrink MM
    JCO Precis Oncol; 2023 Jun; 7():e2200678. PubMed ID: 37343203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dexamethasone on sleep in young children with acute lymphoblastic leukemia.
    Rosen G; Harris AK; Liu M; Dreyfus J; Krueger J; Messinger YH
    Sleep Med; 2015 Apr; 16(4):503-9. PubMed ID: 25799940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL).
    Eiser C; Davies H; Jenney M; Stride C; Glaser A
    Pediatr Blood Cancer; 2006 Jan; 46(1):35-9. PubMed ID: 15926164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study.
    Verwaaijen EJ; van Hulst A; Fiocco M; Hartman A; Grootenhuis M; Pluijm S; Pieters R; van den Akker E; van den Heuvel-Eibrink MM
    JMIR Res Protoc; 2022 Apr; 11(4):e33517. PubMed ID: 35403603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial.
    Warris LT; van den Heuvel-Eibrink MM; Aarsen FK; Pluijm SM; Bierings MB; van den Bos C; Zwaan CM; Thygesen HH; Tissing WJ; Veening MA; Pieters R; van den Akker EL
    J Clin Oncol; 2016 Jul; 34(19):2287-93. PubMed ID: 27161966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of dexamethasone and prednisone on sleep in children with acute lymphoblastic leukemia.
    Daniel LC; Li Y; Kloss JD; Reilly AF; Barakat LP
    Support Care Cancer; 2016 Sep; 24(9):3897-906. PubMed ID: 27108263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment in circadian activity rhythms occurs during dexamethasone therapy in children with leukemia.
    Rogers VE; Zhu S; Ancoli-Israel S; Hinds PS
    Pediatr Blood Cancer; 2014 Nov; 61(11):1986-91. PubMed ID: 25066691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in sleep, fatigue, and daytime activity in a pediatric oncology sample receiving dexamethasone.
    Sanford SD; Okuma JO; Pan J; Srivastava DK; West N; Farr L; Hinds PS
    J Pediatr Psychol; 2008 Apr; 33(3):298-306. PubMed ID: 18024981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia.
    Warris LT; van den Akker EL; Aarsen FK; Bierings MB; van den Bos C; Tissing WJ; Sassen SD; Veening MA; Zwaan CM; Pieters R; van den Heuvel-Eibrink MM
    Psychoneuroendocrinology; 2016 Oct; 72():190-5. PubMed ID: 27448086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL.
    Vallance K; Liu W; Mandrell BN; Panetta JC; Gattuso JS; Hockenberry M; Zupanec S; Yang L; Yang J; Hinds PS
    Eur J Cancer; 2010 Jul; 46(10):1848-55. PubMed ID: 20400291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone.
    Warris LT; van den Akker EL; Bierings MB; van den Bos C; Zwaan CM; Sassen SD; Tissing WJ; Veening MA; Pieters R; van den Heuvel-Eibrink MM
    PLoS One; 2016; 11(6):e0158225. PubMed ID: 27362350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dexamethasone on quality of life in children with acute lymphoblastic leukaemia: a prospective observational study.
    de Vries MA; van Litsenburg RR; Huisman J; Grootenhuis MA; Versluys AB; Kaspers GJ; Gemke RJ
    Health Qual Life Outcomes; 2008 Nov; 6():103. PubMed ID: 19036151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between body mass index and leptin levels in children treated for acute lymphoblastic leukemia during and after maintenance therapy].
    Muszyńska-Rosłan K; Krawczuk-Rybak M; Topczewska M; Sawicka-Zukowska M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(2):91-5. PubMed ID: 16813712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.